The report “Contrast Injector Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector Head, Tubing), Accessories), & Application (Radiology, Interventional Cardiology, Interventional Radiology) – Global Forecast to 2021″, analyzes and studies the major market drivers, restraints/challenges, and opportunities.
This report studies the global contrast injectormarket for the forecast period of 2016 to 2021. This market is expected to reach USD 636.1 Million by 2021 from USD 445.5 Million in 2016, growing at a CAGR of 7.4%.
The contrast injector market growth can primarily be attributed to factors such as the large number of approvals for contrast agents in different geographies and increasing number of public and private diagnostic centers. On the other hand, the side effects and allergic reactions associated with contrast agents are expected to limit the market growth to a certain extent. In the coming years, the contrast media injector market is expected to witness the highest growth rate in the Asia-Pacific region. The high growth in the region can be attributed to the rising approvals for various contrast agents in Asia-Pacific countries, developing markets, and the growing presence of international players in this region. In addition, the availability of government support for research, high healthcare expenditures in APAC countries, rising aging population, and increasing cancer incidences are expected to support the growth of the Asia-Pacific contrast injector market.
Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96046959
The global contrast injector market is segmented on the basis of product, application, and region.
On the basis of product, the contrast injector market is categorized into injector systems, consumables, and accessories. In 2016, the consumables segment is estimated to account for the largest share of the contrast injector market. This growth is mainly attributed to the recurring use of consumables in diagnostic procedures to maintain hygienic conditions. The injector systems segment is further divided into CT injector systems, MRI injector systems, and angiography injector systems. In 2016, the CT injector systems segment is expected to command the largest share of the market. The MRI injector systems segment is expected to grow at the highest CAGR during the forecast period. The consumables segment is further divided into injector heads, syringes, tubing, and other consumables (scan bags, valves, vials, and spikes). In 2016, the injector heads segment is estimated to account for the largest share of the consumables market. The injector heads segment is further categorized into single head injectors, dual head injectors, and syringeless injectors. The single head injectors segment is expected to command the largest share of the market, in 2016. The syringeless injectors segment is projected to grow at the highest CAGR during the forecast period.
On the basis of application, the contrast media injector market is segmented into radiology, interventional cardiology, and interventional radiology. In 2016, the radiology segment is estimated to command the largest share of the contrast injector market. The interventional cardiology segment is expected to grow at the highest CAGR during the forecast period.
Key players in the global contrast injector market include Bracco Imaging S.p.A. (Italy), Bayer HealthCare (Germany), Guerbet Group (France), Medtron AG (Germany), ulrich GmbH & Co. KG (Germany), GE Healthcare (U.S.), AngioDynamics (U.S.), Nemoto Kyorindo Co., Ltd. (Japan), Sino Medical- Device Technology Co., Ltd. (China), VIVID IMAGING (China), and Apollo RT Co., Ltd. (China).
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
newsletter@marketsandmarkets.com
